CRIS Current Research Information System

POTENA, LUCIANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.111
EU - Europa 3.225
AS - Asia 1.474
AF - Africa 194
OC - Oceania 15
SA - Sud America 6
Continente sconosciuto - Info sul continente non disponibili 4
Totale 9.029
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.102
IT - Italia 736
GB - Regno Unito 713
CN - Cina 547
SE - Svezia 516
SG - Singapore 514
DE - Germania 430
UA - Ucraina 225
IN - India 159
IE - Irlanda 153
VN - Vietnam 136
RU - Federazione Russa 107
FR - Francia 101
TG - Togo 65
BG - Bulgaria 56
JO - Giordania 55
ZA - Sudafrica 55
EE - Estonia 41
FI - Finlandia 41
CH - Svizzera 33
CI - Costa d'Avorio 31
NG - Nigeria 25
AT - Austria 22
JP - Giappone 17
SC - Seychelles 17
IR - Iran 16
AU - Australia 14
BE - Belgio 14
NL - Olanda 12
ID - Indonesia 11
CA - Canada 9
GR - Grecia 6
HK - Hong Kong 6
DK - Danimarca 4
EU - Europa 4
KR - Corea 4
LB - Libano 4
PT - Portogallo 4
CL - Cile 3
CZ - Repubblica Ceca 3
RO - Romania 3
BR - Brasile 2
AZ - Azerbaigian 1
CO - Colombia 1
CY - Cipro 1
EG - Egitto 1
HU - Ungheria 1
LT - Lituania 1
MC - Monaco 1
MY - Malesia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
RS - Serbia 1
TR - Turchia 1
Totale 9.029
Salva come PNG Salva come JPEG
Città #
Southend 621
Singapore 473
Fairfield 414
Houston 381
Chandler 364
Ashburn 280
Santa Clara 224
Woodbridge 217
Wilmington 208
Seattle 194
Princeton 182
Dublin 153
Jacksonville 153
Cambridge 151
Ann Arbor 121
Boardman 120
Bologna 115
Bremen 81
New York 72
Westminster 66
Lomé 65
Padova 64
Nanjing 61
Berlin 57
Amman 55
Sofia 55
Beijing 52
Dong Ket 49
Milan 48
Turin 47
Helsinki 39
Shenyang 37
Jinan 35
Mülheim 34
Redmond 32
Abidjan 31
Medford 30
Saint Petersburg 30
Florence 27
Hebei 27
Rome 25
Abeokuta 24
San Diego 24
Bern 23
Changsha 23
Los Angeles 21
Vienna 20
Nanchang 19
Jiaxing 18
Mahé 17
Tianjin 16
Zhengzhou 16
Tokyo 15
Verona 15
Dearborn 14
Brussels 13
Des Moines 13
Reggio Emilia 13
Olalla 12
Shanghai 12
Guangzhou 11
Adelaide 10
Jakarta 10
Kunming 10
Ningbo 10
Taizhou 10
Haikou 9
San Venanzo 9
Monmouth Junction 8
Moscow 8
Taiyuan 8
Xi'an 8
Kuban 7
Parma 7
Shenzhen 7
Falkenstein 6
Hangzhou 6
Hong Kong 6
London 6
Phoenix 6
Toronto 6
Ancona 5
Bari 5
Boydton 5
Buffalo 5
Catania 5
Hyderabad 5
Monteveglio 5
Norwalk 5
Paris 5
Pune 5
Redwood City 5
Shijiazhuang 5
Venice 5
Amsterdam 4
Ardabil 4
Bhubaneswar 4
Bühl 4
Ferrara 4
Forlì 4
Totale 6.075
Salva come PNG Salva come JPEG
Nome #
Impaired dendritic cell immunophenotype and function in heart transplant patients undergoing active cytomegalovirus infection. 332
L'inibitore endogeno della eNOS , la dimetil-arginina simmetrica (ADMA), è un nuovo fattore di rischio di vasculopatia coronarica post trapianto di cuore ed è infulenzato dalla terapia con sirolimus. 285
Changes in exercise capacity induced by heart transplantation: prognostic and therapeutic implications. 179
Clinical relevance of the International Society for Heart and Lung Transplantation consensus classification of primary graft dysfunction after heart transplantation: Epidemiology, risk factors, and outcomes 175
Le complicanze metaboliche post-trapianto di cuore ruolo dell'adiponectina ed associazione con la malattia coronarica del graft 157
Occurrence of Fatal and Nonfatal Adverse Outcomes after Heart Transplantation in Patients with Pretransplant Noncytotoxic HLA Antibodies 156
New pathological insights into cardiac amyloidosis: implications for non-invasive diagnosis. 133
Implications of cardiac resynchronization therapy and prophylactic defibrillator implantation among patients eligible for heart transplantation 132
Monitoring of CMV-specific cell-mediated immunity in heart transplant recipients: clinical utility of the QuantiFERON®-CMV assay for the management of post-transplant CMV infection 132
Prognostic implications of serial assessments of pulmonary hypertension in severe chronic heart failure. 130
Prognostic stratification and treatment of cardiac light chain amyloidosis: a narrow path in the jungle. 130
Ischemic injury activates PTHrP and PTH1R expression in human ventricular cardiomyocytes. 127
Identification and classification of acute cardiac rejection by intragraft transcriptional profiling. 125
Static and dynamic predictors of adverse events in patients with intermediate cardiopulmonary capacity referred for heart transplantation. 125
Cyclosporine lowering with everolimus versus mycophenolate mofetil in heart transplant recipients: Long-term follow-up of the SHIRAKISS randomized, prospective study. 124
Identification of TTR-Related Subclinical Amyloidosis With 99mTc-DPD Scintigraphy 124
Safety and efficacy of early aggressive versus cholesterol-driven lipid-lowering strategies in heart transplantation: A pilot, randomized, intravascular ultrasound study. 124
Long-term safety and effectiveness of statins for heart transplant recipients in routine clinical practice. 123
Diagnosi non invasiva di rigetto miocardico acuto: l'analisi armonica dell'ecg coadiuva la valutazione clinica 122
Clinical and Prognostic Correlates of pAMR Grading in Patients with Suspect Antibody Mediated Rejection 121
Differential effect of everolimus on progression of early and late cardiac allograft vasculopathy in current clinical practice. 121
Hydroxymethyl-glutaryl coenzyme a reductase inhibition limits cytomegalovirus infection in human endothelial cells. 118
Relationship between immune response to SARS-CoV2 vaccines and development of breakthrough infection in solid organ transplant recipients: the CONTRAST cohort 117
Nitrates and Angina: an insight into arterial and venular involvement in blood flow regulation. 117
Prophylaxis versus preemptive therapy for prevention of the consequences of cytomegalovirus infection in transplant recipients: a still unresolved issue 117
Cyclosporine lowering with everolimus or mycophenolate to preserve renal function in heart recipients: a randomized study. 116
Correlazione tra metodi semiquantitativi e quantitativi nella valutazione dell'insufficienza mitralica organica ed associazione con test da sforzo cardiopolmonare e pro-BNP 113
Differential Effect of Everolimus and Metabolic Risk Factors on Early vs. Late Progression of Allograft Vasculopathy: Dissecting Two Faces of the Same Disease 113
Interplay of coronary angiography and intravascular ultrasound in predicting long-term outcomes after heart transplantation 113
Reproducibility of IVUS Measurements in Heart Transplant Recipients: Increased Quality of Data by Using Dedicated Software for Image Analysis 112
Prognostic stratification of women with chronic heart failure referred for heart transplantation: relevance of gender as compared with gender-related characteristics. 111
Manifestations of health anxiety in patients with heart transplant 111
Prophylaxis vs. Pre-Emptive Strategies in Preventing Cytomegalovirus-Dependent Cardiac Allograft Vasculopathy 110
Prophylaxis versus preemptive anti-cytomegalovirus approach for prevention of allograft vasculopathy in heart transplant recipients 110
EVEROLIMUS REDUCES CAV PROGRESSION AS COMPARED WITH AZATHIOPRINE AND MYCOPHENOLATE: A LONGITUDINAL IVUS- BASED STUDY 107
Proliferation signal inhibitors and post-transplant malignancies in heart transplantation: practical clinical management questions. 106
PRE-TRANSPLANT NON-CYTOTOXIC ANTI-HLA ANTIBODIES PREDICT MULTIPLE ADVERSE EVENTS AFTER HEART TRANSPLANTATION 106
Pre-Transplant Non-Cytotoxic Anti-HLA Antibodies Predict Multiple Adverse Events after Heart Transplantation 105
Efficacia e sicurezza dell'ezetimibe in associazione con basse dosi di simvastatina per il trattamento dell'iperlipidemia post-trapianto cardiaco 104
Heart transplantation in hypertrophic cardiomyopathy. 104
Ruolo dell'NT-proBNP nella stratificazione prognostica dei pazienti con scompenso cardiaco cronico. 103
Differential Effects of Everolimus on Early vs. Late Allograft Vasculopathy Progression in Heart Transplant Recipients: a Longitudinal IVUS-Based Study 103
Prevalence of substance-related disorders in heart transplantation candidates 102
Potential of medical treatment, device therapy, and conventional surgery in patients referred for heart transplantation. 101
Cytomegalovirus infectious burden is proportional to cardiac allograft vasculopathy in heart transplant recipients 100
Qualità della vita e parametri clinico-strumentali nello scompenso cardiaco. 98
Psychological predictors of mortality in heart transplanted patients: a prospective, 6-year follow-up study. 97
Late Changes in Maximal Intimal Thickness after Heart Transplant: Prognostic Implications and Risk Factors 96
SAFETY AND EFFICACY OF TWO TYPES OF INFLUENZA VACCINATION IN HEART TRANSPLANT RECIPIENTS: A PROSPECTIVE RANDOMISED CONTROLLED STUDY 96
L'infezione da citomegalovirus e i parametri indicativi di insulino-resistenza influenzano in modo distinto e specifico le variazioni nella geometria coronarica nel primo anno dopo trapianto di cuore 96
Relationship between psychiatric disorders and physical status during the course of a heart transplantation program: a prospective, longitudinal study. 94
Il rallentamento del flusso di perfusione coronarica valutato con il TIMI frame count è in grado di predire la mortalità a lungo termine nei pazienti con trapianto di cuore 94
La progressione della coronarografia del graft è proporzionale alla severità dell'infezione da citomegalovirus nei pazienti con trapianto cardiaco. 93
Safety and efficacy of ezetimibe with low doses of simvastatin in heart transplant recipients. 93
L'inibitore endogeno della eNOS favorisce la progressione dell'infezione da cytoomegalovirus e del rigetto miocardico acuto nei pazienti con trapianto di cuore. 92
Interplay between Pulmonary Hypertension and Donor-Recipient Matching in the Risk for Early Graft Failure after Heart Transplantation 91
Insufficienza mitralica organica: parametri ecocardiografici, funzionali e neuro-ormonali potenziali predittori di intervento chirurgico a breve termine 90
Relevance of cardioverter defibrillators for the prevention of sudden cardiac death on the timing of heart transplantation. 90
Coronary allograft vasculopathy: pathophysiological interaction between the immune system, infections and metabolic syndrome 89
Everolimus in kidney transplant recipients at high cardiovascular risk: a narrative review 87
null 85
Extracorporeal Membrane Oxygenation Support System as Bridge to Solution in Refractory Cardiogenic Shock 83
Update and review: state-of-the-art management of cytomegalovirus infection and disease following thoracic organ transplantation. 83
L'infezione subclinica da citomegalovirus modula l'infiammazione sistemica e il rimodellamento coronarico ad un anno dal trapianto. 82
Extracorporeal membrane oxygenation for the treatment of refractory cardiogenic shock in adults: strategies, results, and predictors of mortality = Sistemi di ossigenazione a membrana extracorporea come trattamento per lo shock cardiogeno refrattario nella popolazione adulta: strategie, risultati e predittori di mortalità 81
Impact of Current Donor Scores Calculation on Heart Transplantation Outcomes 80
Viral genome search in myocardium of patients with fulminant myocarditis 77
Evaluation of the Kinetics of Antibody Response to COVID-19 Vaccine in Solid Organ Transplant Recipients: The Prospective Multicenter ORCHESTRA Cohort 75
Evaluating sacubitril/valsartan as a treatment option for heart failure with reduced ejection fraction and preserved ejection fraction 75
Role of Donor-Recipient Match in Determining the Risk for Primary Graft Failure after Heart Transplantation 72
Fulminant Versus Acute Nonfulminant Myocarditis in Patients With Left Ventricular Systolic Dysfunction 72
Study Design and Preliminary Results of the Italian Everolimus Registry CERTIC 71
Using machine learning to predict antibody response to SARS-CoV-2 vaccination in solid organ transplant recipients: the multicentre ORCHESTRA cohort 69
Studio prospettico randomizzato sull'effetto della terapia con acido folico nella preenzione della malattia coronarica nel paziente trapiantato 69
COVID-19 in Heart Transplant Recipients: A Multicenter Analysis of the Northern Italian Outbreak 67
Impact of prior sternotomy on survival and allograft function after heart transplantation: A single center matched analysis 65
Management of heart transplant candidates in the time of COVID-19 pandemic: Looking for answers 62
Donor risk analysis and validation in heart transplants: A single-centre experience 57
Donor-derived human herpesvirus 8 infection with Kaposi sarcoma and Kaposi sarcoma inflammatory cytokine syndrome in a heart transplant recipient: A case report 56
Multiple organ retrieval in a brain dead left ventricular assist device donor 51
Impact of Predicted Heart Mass–Based Donor-Recipient Size Matching on Transplant Outcomes 47
Multicenter Prospective Study for Laboratory Diagnosis of HHV8 Infection in Solid Organ Donors and Transplant Recipients and Evaluation of the Clinical Impact After Transplantation 46
Heart rate reserve during dipyridamole stress test applied to potential heart donors in brain death 45
Histopathological comparison of intramural coronary artery remodeling and myocardial fibrosis in obstructive versus end-stage hypertrophic cardiomyopathy 45
Evidence and current use of levosimendan in the treatment of heart failure: Filling the gap 44
Clinical presentations leading to arrhythmogenic left ventricular cardiomyopathy 40
Differences in cardiac phenotype and natural history of laminopathies with and without neuromuscular onset 38
Clinical profile and in-hospital outcome of patients supported by intra-aortic balloon pump in the clinical setting of cardiogenic shock 38
Correlations Between Cardiac Magnetic Resonance and Myocardial Histologic Findings in Fabry Disease 35
Post-discharge arrhythmic risk stratification of patients with acute myocarditis and life-threatening ventricular tachyarrhythmias 35
Does therapeutic drug monitoring (TDM) of trough concentrations suffice for optimizing preemptive therapy with ganciclovir of cytomegalovirus infections in non-renal solid organ transplant recipients? 33
Candidacy for heart transplantation in adult congenital heart disease patients: A cohort study 32
Effect of a Fourth Dose of mRNA Vaccine and of Immunosuppression in Preventing SARS-CoV-2 Breakthrough Infections in Heart Transplant Patients 30
Pretransplant Right Ventricular Dysfunction Is Associated With Increased Mortality After Heart Transplantation: A Hard Inheritance to Overcome 28
Cardiovascular Toxicity of Immune Checkpoint Inhibitors: A Guide for Clinicians 26
Overcoming challenges in patient selection and monitoring in combined heart and kidney transplantation 19
Role of Quantitative Flow Ratio in Predicting Future Cardiac Allograft Vasculopathy in Heart Transplant Recipients 18
Longest reported support (7.5 years) with postauricular type of Jarvik 2000 axial-flow left ventricular assist device 17
New insights into the oncological risk in heart transplant recipients: could skin tumors represent a marker of increased risk for solid neoplasm? 17
Prolactin Inhibition to Treat Postpartum Arrhythmic Storm 15
Totale 9.272
Salva come PNG Salva come JPEG
Categoria #
all - tutte 25.744
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.744
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.217 0 0 0 0 0 216 214 229 231 133 76 118
2020/2021927 220 59 24 56 26 38 53 45 78 66 42 220
2021/20221.475 60 49 96 210 119 62 39 113 59 139 297 232
2022/20231.940 171 236 100 231 172 174 50 106 359 77 183 81
2023/2024698 36 98 36 72 29 164 41 54 33 55 27 53
2024/20251.411 150 389 201 194 358 119 0 0 0 0 0 0
Totale 9.300